News | December 19, 2014

Two Guidelines Added to ACC Guideline Clinical App

App provides mobile access to guidelines, tools for treatment, prevention of heart disease

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and atrial fibrillation.

The ACC Guideline Clinical App was launched in November with the initial version including content based on guidelines for heart failure, cardiovascular risk assessment and treatment of blood cholesterol. In addition to the Executive Summary and Top 10 Points for each guideline, the app includes a collection of interactive tools such as dosing calculators, scoring tools and algorithms useful to clinicians in determining recommended care.

The ACC, which has been developing clinical practice guidelines in partnership with the American Heart Association for more than three decades, developed this app to serve as a mobile home for all ACC/AHA guideline content and related tools.

The ACC will continue to refine and expand the app. An additional update is expected in March with content and tools based on guidelines for the treatment of obesity and the management of lifestyle to reduce cardiovascular risk.

The American College of Cardiology Guideline Clinical App is available for free on iTunes and GooglePlay.

For more information: www.acc.org

 


Related Content

News | Heart Valve Technology

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
News | Heart Valve Technology

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
News | Heart Valve Technology

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
News | Heart Valve Technology

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
News | Heart Valve Technology

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
News | Heart Valve Technology

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...

Home December 12, 2023
Home
News | Heart Valve Technology

November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its ...

Home November 20, 2023
Home
News | Heart Valve Technology

October 24, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announced that novel data from seven research studies ...

Home October 24, 2023
Home
News | Heart Valve Technology

October 17, 2023 — The Patel Children's Heart Institute at St. Joseph's Children's Hospital achieved a milestone ...

Home October 17, 2023
Home
Subscribe Now